Skip to content
Screener

INmune Bio INMB Q1 2025 earnings

Reported May 8, 2025 · After market close

Revenue$50.0K
EPS-$0.43In line
EPS estimate-$0.43

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.9M
EPS estimate-$0.15

FAQ

When did INmune Bio report Q1 2025 earnings?
INmune Bio (INMB) reported Q1 2025 earnings on May 8, 2025 after market close.
What were INmune Bio's Q1 2025 revenue and EPS?
INmune Bio reported revenue of $50.0K and eps of $-0.43 for Q1 2025.
Did INmune Bio beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.43 by $0.00.
How did INmune Bio's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 257.1% from $14.0K a year earlier and eps grew 29.5% from $-0.61.
Where can I find INmune Bio's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-039733) and the 10-Q periodic report (0001213900-25-041072) directly on SEC EDGAR. The filing index links above go to sec.gov.